All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AXSOME THERAPEUTICS, INC.: Last Reported 3/31/2020

Business Address

200 BROADWAY, 3RD FLOOR

NEW YORK, NY US 10038

Mailing Address

200 BROADWAY, 3RD FLOOR

NEW YORK, NY US 10038
Phone Number: (212) 332-3241 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 11/30/2015 10/31/2015 9/30/2015 6/30/2015 4/30/2015 3/31/2015 12/31/2014 12/31/2013
Cash and Cash Equivalents -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $309,370.00 $413,095.00 $594,345.00 $814,913.00 $1,134,692.00 $1,246,360.00 $723,669.00 $1,187,961.00 $1,121,003.00 $1,278,418.00 $746,094.00 $842,597.00 $1,179,124.00 $1,380,560.00 $867,099.00 $1,164,873.00 $987,552.00 $996,618.00 -- -- -- -- -- -- -- --
Total Current Assets $197,622,778.00 $220,379,262.00 $44,236,206.00 $54,568,050.00 $43,759,179.00 $15,215,102.00 $15,944,433.00 $21,539,404.00 $27,753,698.00 $35,299,541.00 $32,419,477.00 $38,837,046.00 $46,198,751.00 $37,999,057.00 $34,754,903.00 $39,916,623.00 $45,065,552.00 $49,032,878.00 -- -- -- -- -- -- -- --
Property Plant and Equipement $34,518.00 $30,623.00 $34,554.00 $40,747.00 $40,393.00 $51,832.00 $64,039.00 $68,635.00 $70,709.00 $68,071.00 $79,344.00 $86,524.00 $93,516.00 $100,730.00 $104,426.00 $33,790.00 $25,192.00 $16,653.00 -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $143,575.00 $139,875.00 $168,969.00 $168,969.00 $101,516.00 $112,345.00 $117,356.00 $117,356.00 $114,889.00 $187,952.00 $119,291.00 $119,291.00 $119,291.00 $112,821.00 $59,125.00 $57,500.00 $57,500.00 $26,625.00 -- -- -- -- -- -- -- --
Total Assets $197,800,871.00 $220,549,760.00 $44,439,729.00 $54,777,766.00 $43,901,088.00 $15,379,279.00 $16,125,828.00 $21,725,395.00 $27,939,296.00 $35,555,564.00 $32,618,112.00 $39,042,861.00 $46,411,558.00 $38,212,608.00 $34,918,454.00 $40,007,913.00 $45,148,244.00 $49,076,156.00 -- -- -- -- -- -- -- --
Accounts Payable $12,191,714.00 $10,943,325.00 $9,447,359.00 $6,137,120.00 $3,434,184.00 $3,687,245.00 $4,167,369.00 $3,175,178.00 $3,874,592.00 $3,435,456.00 $2,942,999.00 $4,038,645.00 $4,740,702.00 $4,081,173.00 $3,867,584.00 $3,035,038.00 $1,830,422.00 $1,892,363.00 -- -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- $3,387,771.00 $2,953,631.00 $2,153,051.00 $2,679,534.00 $2,743,575.00 $2,276,750.00 $2,535,124.00 $2,820,377.00 $2,867,952.00 $2,068,520.00 $2,083,310.00 $739,532.00 -- -- -- -- -- -- -- --
Total Current Liabilities $41,644,005.00 $41,827,371.00 $37,617,133.00 $30,494,821.00 $26,527,389.00 $14,441,358.00 $15,383,071.00 $14,716,496.00 $15,353,142.00 $18,838,341.00 $15,779,055.00 $16,288,253.00 $17,131,078.00 $16,641,157.00 -- -- -- $2,631,895.00 -- -- -- -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-208,400,000.00 $-175,895,493.00 $-151,100,000.00 $-131,952,897.00 $-118,190,683.00 $-107,550,307.00 $-97,953,292.00 $-89,671,318.00 $-81,390,402.00 $-76,584,843.00 $-69,154,342.00 $-62,720,806.00 $-55,636,490.00 $-47,641,451.00 $-40,312,513.00 $-33,117,929.00 $-24,654,739.00 $-18,788,798.00 -- -- -- -- -- -- -- --
Total Stockholders' Equity $156,156,866.00 $178,722,389.00 $6,822,596.00 $24,282,945.00 $17,373,699.00 $937,921.00 $742,757.00 $7,008,899.00 $12,586,154.00 $16,717,223.00 $16,839,057.00 $22,754,608.00 $29,280,480.00 $21,571,451.00 $28,182,918.00 $34,904,355.00 $41,234,512.00 $46,444,261.00 -- -- -- -- -- -- $-3,202,575.00 $-2,027,811.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $197,800,871.00 $220,549,760.00 $44,439,729.00 $54,777,766.00 $43,901,088.00 $15,379,279.00 $16,125,828.00 $21,725,395.00 $27,939,296.00 $35,555,564.00 $32,618,112.00 $39,042,861.00 $46,411,558.00 $38,212,608.00 $34,918,454.00 $40,007,913.00 $45,148,244.00 $49,076,156.00 -- -- -- -- -- -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 11/30/2015 10/31/2015 9/30/2015 6/30/2015 4/30/2015 3/31/2015 12/31/2014 12/31/2013
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $27,521,400.00 $53,647,067.00 $34,441,796.00 $11,003,142.00 $7,603,081.00 $23,495,055.00 $16,343,823.00 $10,303,043.00 $4,752,511.00 $19,957,616.00 $15,463,706.00 $10,992,580.00 $5,985,219.00 $21,199,860.00 $15,393,089.00 $5,298,060.00 $4,526,252.00 $6,776,987.00 -- -- $4,569,072.00 $3,044,677.00 -- $1,416,283.00 $4,279,200.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $32,491,457.00 $67,245,097.00 $18,947,235.00 $13,448,219.00 $10,421,473.00 $32,846,577.00 $8,243,459.00 $7,989,593.00 $7,163,210.00 $27,164,307.00 $6,297,416.00 $14,422,771.00 $7,672,033.00 $27,543,508.00 $19,917,948.00 $12,710,145.00 $5,882,865.00 $9,196,276.00 -- -- $6,041,743.00 $2,084,804.00 -- $1,933,123.00 $5,672,030.00 --
Loss from Operations $-32,491,457.00 $-67,245,097.00 $-18,947,235.00 $-13,448,219.00 $-10,421,473.00 $9,450,315.00 $-23,396,262.00 $-15,152,803.00 $-7,163,210.00 $6,444,120.00 $-20,720,187.00 $6,750,738.00 $-7,672,033.00 $-27,543,508.00 $-7,207,803.00 $6,827,280.00 $-5,882,865.00 $-9,196,276.00 -- -- $-6,041,743.00 $-4,017,927.00 -- $-1,933,123.00 $-5,672,030.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 25,000,000 -- -- 22,033,500 -- 14,689,000 --
Common Stock Shares Outstanding 37,075,422 36,933,217 34,496,846 34,330,441 33,304,047 30,087,213 26,458,662 26,252,562 25,549,892 25,492,992 23,665,532 23,608,084 23,543,667 19,158,417 19,153,417 19,149,417 19,149,417 19,149,417 -- -- -- -- -- -- -- --
Copyright 2020 PursePoor.com